Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis?
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.01159-24 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Laura Melotti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Colitis, Ulcerative, Cytomegalovirus, DNA, Viral. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cytomegalovirus (CMV) colitis is a serious concern worsening the prognosis of patients with ulcerative colitis (UC). We aimed to assess risk factors and prognostic impact of CMV colitis in patients with moderate-to-severe UC flare. We conducted a retrospective, observational, single-center study. Consecutive adult patients hospitalized for moderate-to-severe UC from January 2020 to June 2023 were included. The primary endpoint was a diagnosis of CMV-colitis according to immunohistochemistry on tissue biopsies. The secondary endpoint was the need for colectomy within 30 days. Overall, 135 patients were included. CMV colitis was diagnosed in n = 37 (27.4%): n = 19 (51.4%) endoscopically, the remaining on surgical specimens. Of them, n = 23 (62.2%) had positive CMV-DNAemia with a median value of 1,008 cp/mL (interquartile range 318–2,980). Differences between the two groups (CMV colitis vs non-CMV) included age (60 vs 41 years, P = 0.004), Charlson Comorbidity Index (1 vs 0, P = 0.003), steroid refractoriness (86.5% vs 62.2%, P = 0.007), and positive CMV-DNAemia (62.2% vs 10.1%, P < 0.001). At multivariable analysis, steroid-refractory disease, Charlson Comorbidity Index, and CMV-DNAemia were associated with CMV colitis. Overall, n = 54 (39.7%) patients underwent colectomy, and this was significantly more common in patients with CMV colitis vs non-CMV group (54.1% vs 34.4%, P = 0.049). Kaplan-Meier showed that antiviral therapy seems to have a relevant impact on colectomy ( P < 0.001). CMV-DNA blood detection is independently associated with CMV-positive refractory UC. Since CMV colitis may increase the risk of colectomy and antiviral treatment seems to reduce such risk, prospective studies are needed to confirm the role of CMV-DNA blood detection to early diagnose CMV colitis. IMPORTANCE Cytomegalovirus (CMV) colonic reactivation worsens the prognosis of patients with active ulcerative colitis. Blood CMV-DNA reactivation is strongly associated with CMV colitis. Prompt diagnosis and treatment of CMV colitis can avoid surgery in most cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
- Dept of Medical and Surgical Sciences, IBD Unit- IRCCS Azienda Ospedaliero-Universitaria- Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
- Infectious Disease Unit, Department for Integrated Risk Management, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
ORCID-Profile: Matteo Rinaldi
Zitieren
APA
Melotti, L., Rinaldi, M., Salice, M., Dussias, N. K., Vanigli, N., Calabrese, C., Scaioli, E., Gabrielli, L., Lazzarotto, T., Rosini, F., Viale, P., Gionchetti, P., Giannella, M., & Rizzello, F. (2024). Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis?. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01159-24
Vancouver
Melotti L, Rinaldi M, Salice M, Dussias NK, Vanigli N, Calabrese C, et al. Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis?. Microbiology Spectrum. 2024. doi:10.1128/spectrum.01159-24
BibTeX
@article{Melotti2024,
author = {Melotti, Laura and Rinaldi, Matteo and Salice, Marco and Dussias, Nikolas K and Vanigli, Nicholas and Calabrese, Carlo and Scaioli, Eleonora and Gabrielli, Liliana and Lazzarotto, Tiziana and Rosini, Francesca and Viale, Pierluigi and Gionchetti, Paolo and Giannella, Maddalena and Rizzello, Fernando},
title = {Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis?},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.01159-24}
}
EUVIMED